Old Web
English
Sign In
Acemap
>
Paper
>
56The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension
56The SGLT2 inhibitor empagliflozin reduces mortality in experimental pulmonary hypertension
2019
Biswajit Chowdhury
V Z Luu
A Z Luu
M G Kabir
Yi Pan
Hwee Teoh
Adrian Quan
C.D. Mazer
Subodh Verma
Keywords:
Pulmonary hypertension
SGLT2 Inhibitor
Diabetes mellitus
Cardiology
Internal medicine
Empagliflozin
Medicine
Hemodynamics
Blood pressure
Heart failure
Lung
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]